GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...

According to the Centers for Disease Control and Prevention, the strain is now the third most common COVID-19 variant in the United States.

Patients in England with advanced head and neck cancer are being fast-tracked into a groundbreaking mRNA cancer vaccine trial, a ...